Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18

Yoshikazu Sugimoto, Etsuko Okochi, Hirofumi Hamada, Tomoko Oh-hara, Takashi Tsuruo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To characterize the membrane changes related to adriamycin (ADM) resistance in tumor cells, we have developed monoclonal antibodies against an ADM-resistant subline of human myelogenous leukemia K562 ( K562 ADM), and reported the overexpression of P-glycoprotein and 85-kDa protein as determined by the antibodies. In the present study, we have established a monoclonal antibody, MRK18, with higher reactivity to K562 ADM than to K562. MRK18 also showed higher reactivity to other human ADM-resistant lines, 2780AD and Hattori/ADM, than the corresponding parental lines. MRK18 also reacted to human breast cancer MCF-7 and human T-lymphoma CCRF-CEM which have never been exposed to anticancer agents in culture. MRK18 recognized a 300-kDa membrane protein of K562 ADM and MCF-7 and inhibited the growth of these cell lines in culture. These results indicate an induction of the 300-kDa protein during the development of ADM resistance.

Original languageEnglish
Pages (from-to)686-691
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume169
Issue number2
DOIs
Publication statusPublished - 1990 Jun 15
Externally publishedYes

Fingerprint

Doxorubicin
Tumors
Membrane Proteins
Monoclonal Antibodies
Cells
Neoplasms
Myeloid Leukemia
P-Glycoprotein
Cell culture
Antineoplastic Agents
Lymphoma
Proteins
Breast Neoplasms
Membranes
Cell Line
Antibodies
Growth

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18. / Sugimoto, Yoshikazu; Okochi, Etsuko; Hamada, Hirofumi; Oh-hara, Tomoko; Tsuruo, Takashi.

In: Biochemical and Biophysical Research Communications, Vol. 169, No. 2, 15.06.1990, p. 686-691.

Research output: Contribution to journalArticle

@article{907cfb6f9f964260a929bbced2fcdd21,
title = "Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18",
abstract = "To characterize the membrane changes related to adriamycin (ADM) resistance in tumor cells, we have developed monoclonal antibodies against an ADM-resistant subline of human myelogenous leukemia K562 ( K562 ADM), and reported the overexpression of P-glycoprotein and 85-kDa protein as determined by the antibodies. In the present study, we have established a monoclonal antibody, MRK18, with higher reactivity to K562 ADM than to K562. MRK18 also showed higher reactivity to other human ADM-resistant lines, 2780AD and Hattori/ADM, than the corresponding parental lines. MRK18 also reacted to human breast cancer MCF-7 and human T-lymphoma CCRF-CEM which have never been exposed to anticancer agents in culture. MRK18 recognized a 300-kDa membrane protein of K562 ADM and MCF-7 and inhibited the growth of these cell lines in culture. These results indicate an induction of the 300-kDa protein during the development of ADM resistance.",
author = "Yoshikazu Sugimoto and Etsuko Okochi and Hirofumi Hamada and Tomoko Oh-hara and Takashi Tsuruo",
year = "1990",
month = "6",
day = "15",
doi = "10.1016/0006-291X(90)90385-Z",
language = "English",
volume = "169",
pages = "686--691",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18

AU - Sugimoto, Yoshikazu

AU - Okochi, Etsuko

AU - Hamada, Hirofumi

AU - Oh-hara, Tomoko

AU - Tsuruo, Takashi

PY - 1990/6/15

Y1 - 1990/6/15

N2 - To characterize the membrane changes related to adriamycin (ADM) resistance in tumor cells, we have developed monoclonal antibodies against an ADM-resistant subline of human myelogenous leukemia K562 ( K562 ADM), and reported the overexpression of P-glycoprotein and 85-kDa protein as determined by the antibodies. In the present study, we have established a monoclonal antibody, MRK18, with higher reactivity to K562 ADM than to K562. MRK18 also showed higher reactivity to other human ADM-resistant lines, 2780AD and Hattori/ADM, than the corresponding parental lines. MRK18 also reacted to human breast cancer MCF-7 and human T-lymphoma CCRF-CEM which have never been exposed to anticancer agents in culture. MRK18 recognized a 300-kDa membrane protein of K562 ADM and MCF-7 and inhibited the growth of these cell lines in culture. These results indicate an induction of the 300-kDa protein during the development of ADM resistance.

AB - To characterize the membrane changes related to adriamycin (ADM) resistance in tumor cells, we have developed monoclonal antibodies against an ADM-resistant subline of human myelogenous leukemia K562 ( K562 ADM), and reported the overexpression of P-glycoprotein and 85-kDa protein as determined by the antibodies. In the present study, we have established a monoclonal antibody, MRK18, with higher reactivity to K562 ADM than to K562. MRK18 also showed higher reactivity to other human ADM-resistant lines, 2780AD and Hattori/ADM, than the corresponding parental lines. MRK18 also reacted to human breast cancer MCF-7 and human T-lymphoma CCRF-CEM which have never been exposed to anticancer agents in culture. MRK18 recognized a 300-kDa membrane protein of K562 ADM and MCF-7 and inhibited the growth of these cell lines in culture. These results indicate an induction of the 300-kDa protein during the development of ADM resistance.

UR - http://www.scopus.com/inward/record.url?scp=0025374517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025374517&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(90)90385-Z

DO - 10.1016/0006-291X(90)90385-Z

M3 - Article

VL - 169

SP - 686

EP - 691

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -